rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

David J. Endicott

Director

Company insider

Files Form 4 as: Director, MiniMed Group; Director, Orexigen Therapeutics; Director, Zeltiq Aesthetics; Pres., Hospira Medical Devices, Hospira; CVP and President, AGN Med, Allergan.

Every Form 4 they filed

In numbers

Trades disclosed
41
Buys
0
Sells
3
Bought
$0
Sold
$7.6M
Companies
5
Companies where not an officer
3
First trade
17 Feb 2012
Last trade
15 Oct 2026
Last filed
16 Oct 2026

Companies traded

Where they are an officer
HospiraOfficer · last 3 Sep 20150 buys · 0 sells
AllerganOfficer · last 21 Feb 20130 buys · 3 sells
Everywhere else they filed: board seats, 10% stakes, other companies
MMED MiniMed GroupDirector · Medical Devices · last 15 Oct 20260 buys · 0 sells
Orexigen TherapeuticsDirector · last 14 Jul 20170 buys · 0 sells
Zeltiq AestheticsDirector · last 28 Apr 20170 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
15 Oct 2026filed 16 Oct 2026MMED MiniMed GroupMedical DevicesSEC FORM 4 Code A—3,374 at $0.00filing
9 Oct 2026filed 13 Oct 2026MMED MiniMed GroupMedical DevicesSEC FORM 4 Code A—11,795 at $0.00filing
14 Jul 2017filed 18 Jul 2017Orexigen Therapeuticsoption or derivativeSEC FORM 4 Code A—5,000 at $0.00filing
28 Apr 2017filed 28 Apr 2017Zeltiq AestheticsSEC FORM 4 Code J—16,132filing
12 Jul 2016filed 14 Jul 2016Orexigen Therapeuticsoption or derivativeSEC FORM 4 Code A—15,000filing
16 Jun 2016filed 23 Jun 2016Zeltiq AestheticsSEC FORM 4 Code A$175K6,199 at $28.23filing
25 Apr 2016filed 26 Apr 2016Zeltiq AestheticsSEC FORM 4 Code A—9,933 at $0.00filing
3 Sep 2015filed 3 Sep 2015HospiraSEC FORM 4 Code A—15,196 at $0.00filing
3 Sep 2015filed 3 Sep 2015HospiraSEC FORM 4 Code M$3.1M72,971 at $43.01filing
3 Sep 2015filed 3 Sep 2015HospiraSEC FORM 4 Code D$18.5M205,668 at $90.00filing
3 Sep 2015filed 3 Sep 2015Hospiraoption or derivativeSEC FORM 4 Code M—72,971 at $0.00filing
9 Jun 2015filed 10 Jun 2015Orexigen Therapeuticsoption or derivativeSEC FORM 4 Code A—50,000filing
25 Feb 2015filed 27 Feb 2015HospiraSEC FORM 4 Code A$3.5M40,000 at $87.50filing
27 Jun 2014filed 27 Jun 2014Orexigen Therapeuticsoption or derivativeSEC FORM 4 Code A—50,000filing
31 Mar 2014filed 2 Apr 2014HospiraSEC FORM 4 Code A$833K19,375 at $43.01filing
31 Mar 2014filed 2 Apr 2014HospiraSEC FORM 4 Code A$2.5M58,126 at $43.01filing
31 Mar 2014filed 2 Apr 2014Hospiraoption or derivativeSEC FORM 4 Code A—72,971 at $0.00filing
5 Jun 2013filed 28 Aug 2013Orexigen Therapeuticsoption or derivativeSEC FORM 4 Code A—18,126filing
5 Jun 2013filed 7 Jun 2013Orexigen Therapeuticsoption or derivativeSEC FORM 4 Code A—35,000filing
21 Feb 2013filed 22 Feb 2013Allerganoption or derivativeSEC FORM 4 Code A—40,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Not placed3

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.